Device Trial Radar · NCT05684146
Protect the Head to Head Study
Last checked: Nov 19, 2026Latest source record: May 19, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
540
Planned (sponsor's estimate)
Start
May 4, 2023
Primary completion
Oct 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- EmbolineNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, randomized, open label, multicenter, 2-arm, safety and efficacy study
Conditions
- Embolism
Interventions
Emboliner Embolic ProtectionDevice
Emboliner Embolic Protection Device will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) interventions
Sentinel Cerebral ProtectionDevice
The Sentinel Cerebral Protection System will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) interventions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Non-inferiorityTime frame: Non-inferiority of 30-day Emboliner device MACCE patient incidence rate compared to the Sentinel device patient incidence rate.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
NewYork-Presbyterian/Columbia University Medical Center
New York, New York · Recruiting
Oklahoma Heart Institute
Tulsa, Oklahoma · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.